Table 4.
Changes in Metabolic Markers and Liver Functions Between the Resistance (n = 14) and Aerobic (n = 13) Groups
| Variables | Group | Before | After | Change | p for Difference | p for Interaction |
|---|---|---|---|---|---|---|
| Total cholesterol, mg/dl | RE | 205.21±37.77 | 201.43±44.88 | −3.79±22.98 | 0.55 | 0.947 |
| AE | 199.85±42.75 | 195.15±37.83 | −4.69±11.94 | 0.18 | ||
| LDL cholesterol, mg/dl | RE | 129.93±32.40 | 124.71±39.58 | −5.21±23.43 | 0.42 | 0.618 |
| AE | 119.62±50.81 | 117.46±41.22 | −2.15±17.03 | 0.66 | ||
| HDL cholesterol, mg/dl | RE | 52.00±9.81 | 52.14±10.17 | 0.14±6.97 | 0.94 | 0.640 |
| AE | 56.85±0.09 | 57.92±13.48 | 1.08±5.27 | 0.48 | ||
| Triglycerides, mg/dl | RE | 147.79±112.30 | 136.93±77.97 | −10.86±50.14 | 0.43 | 0.886 |
| AE | 127.39±89.30 | 120.31±99.20 | −7.08±66.47 | 0.71 | ||
| Fasting blood glucose, mg/dl | RE | 99.29±11.30 | 100.36±16.63 | 1.07±8.21 | 0.63 | 0.646 |
| AE | 98.08±13.62 | 97.23±11.41 | −0.85±8.24 | 0.72 | ||
| HOMA-IR | RE | 2.15±1.15 | 2.07±1.14 | −0.08±0.63 | 0.64 | 0.387 |
| AE | 2.24±1.16 | 1.88±0.81 | −0.35±0.84 | 0.15 | ||
| AST, U/L | RE | 24.86±5.68 | 23.79±4.71 | −1.07±6.34 | 0.54 | 0.762 |
| AE | 21.62±5.55 | 21.15±5.13 | −0.46±3.86 | 0.67 | ||
| ALT, U/L | RE | 31.21±8.89 | 26.14±9.02 | −5.07±6.73 | < 0.05 | 0.325 |
| AE | 26.00±11.86 | 23.15±7.23 | −2.85±6.85 | 0.16 | ||
| γ-GTP, U/L | RE | 56.71±46.01 | 39.50±19.78 | −17.21±27.58 | < 0.05 | 0.055 |
| AE | 49.92±30.94 | 46.46±28.93 | −3.46±7.71 | 0.13 |
Notes: Values are means ± SD.
Abbreviations: LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, gamma-glutamyl transpeptidase.